Phibro Animal Health will acquire product portfolio from Zoetis

April 30, 2024

The $350 deal includes medicated feed additive products, certain water soluble products, and related assets.
Photo: Jonatan Rundblad/Adobe Stock
Phibro Animal Health will acquire Zoetis’ medicated feed additive (MFA) product portfolio, certain water soluble products and related assets for $350 million. The 2 parties announced the definitive agreement on Sunday, April 28, 2024, in a joint news release.
The product portfolio is comprised of more than 37 product lines that are sold in ap
This post WAS generated by Author with the help of AI .

DVM360 https://www.dvm360.com/

dvm360.com is the official website for the renowned veterinary publication dvm360® magazine. As a giant in the industry, dvm360 provides veterinary professionals with comprehensive resources and information to help enhance patient care and client services. We cover every angle of veterinary medicine from recent technological advancements to clinical insights to effective managerial strategies.

Leopard | Basics about leopards

Male cat’s nipples and teats.

popcorning behavior in guinea pig – sudden jumping behaviour

An inspiring story of a Stray Cat Who Lost All Four Legs and Her Tail but still lives well.

WSAVA announces “Essentials of Canine and Feline Gastroenterology” course.

Phibro Animal Health will acquire product portfolio from Zoetis

Researchers develop rapid detection tool for swine disease

Flex Forecast: May 2024

Sneak peek: USDA now requiring HPAI testing for lactating dairy cattle prior to transportation, and other veterinary news

First generic pimobendan chewable tablets for canine congestive heart failure receives FDA approval

Leave a reply Cancel reply

Owner survey finds alarming attitudes towards parasite prevention

VHMS awards CVPM credential to 28 practice managers